Sinai Hospital

Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting

Retrieved on: 
Thursday, March 14, 2024
Blood pressure, Sinai Hospital, Anaphylaxis, Absorption, Angioedema, Plasma, Type, PD, Patient, Heart rate, Adrenaline, NDA, Epinephrine autoinjector, Cmax, Trial of the century, Mouth, Therapy, Safety, Oral medicine, Allergy, Vomiting, Swelling, FDA, Study, Food, Pharmaceutical industry

“We are extremely pleased with the pivotal study results as well as our recent FDA interaction,” said Daniel Barber, President and Chief Executive Officer of Aquestive.

Key Points: 
  • “We are extremely pleased with the pivotal study results as well as our recent FDA interaction,” said Daniel Barber, President and Chief Executive Officer of Aquestive.
  • “We believe we have a clear understanding of the remaining clinical development steps necessary for a pre-NDA meeting with the FDA in the second half of the year.
  • These latest study results show that the sublingual administration of epinephrine provides rapid and sustained levels of epinephrine similar to approved treatments.
  • The FDA noted that substantial progress had been made in the Anaphylm clinical development program and did not outline any new clinical development requirements.

UNFO Introduces Innovative Corrective Foot Brace For Newborns, Elevating Pediatric Orthopedic Care In The U.S.

Retrieved on: 
Tuesday, January 16, 2024
Sinai Hospital, Toe, Patient, Research, Orthopedic surgery, Gait, Mount Sinai Hospital, Foot, International Center, Ankle, MTA, Risk, TEL, Elective surgery, DSM-IV codes, Child, FDA, Retirement, Parent, Tarsometatarsal joints, Infant, Nursing

TEL AVIV, Israel, Jan. 16, 2024 /PRNewswire/ -- UNFO Med Ltd., the manufacturer of the Universal Neonatal Foot Orthotics (UNFO) system, is thrilled to introduce a first of its kind corrective foot brace for the treatment of various foot conditions such as Metatarsus Adductus (MTA), a common condition in newborns that causes the front half of the foot, or forefoot, to turn inward. Other conditions include Metatarsus Varus, forefoot adduction, intoeing, and skew foot. This development marks a significant milestone in pediatric orthopedic care, replacing the need for casting and surgical intervention.

Key Points: 
  • This development marks a significant milestone in pediatric orthopedic care, replacing the need for casting and surgical intervention.
  • Metatarsus Adductus – also known as MTA – is a congenital foot condition that occurs in approximately 7% of births.
  • Following seven years of dedicated research, he unveiled UNFO, a short foot orthotic device worn below the ankle.
  • Dr. Daizade has treated over 15,000 patients with the UNFO brace and has had a 95% rate of success[1].

Dr. Rachel Brem joins Breathe BioMedical as Executive Director and Chief Medical Officer

Retrieved on: 
Tuesday, January 9, 2024
Mortality, Artificial intelligence, Woman, Sinai Hospital, Johns Hopkins Hospital, Regulation, Legislation, Internal medicine, Newsweek, BBM, Health equity, George Washington University, Breast cancer, Clinical, Executive, Breast imaging, Radiology, Regular-Irregular, Executive director, Organization, Education, Diagnosis, Trial of the century, Medical imaging

MONCTON, NB, Jan. 9, 2024 /PRNewswire/ - Breathe BioMedical (BBM) is pleased to announce the appointment of Dr. Rachel Brem to the company's Board of Directors in her newly appointed role of Executive Director and Chief Medical Officer.

Key Points: 
  • MONCTON, NB, Jan. 9, 2024 /PRNewswire/ - Breathe BioMedical (BBM) is pleased to announce the appointment of Dr. Rachel Brem to the company's Board of Directors in her newly appointed role of Executive Director and Chief Medical Officer.
  • Dr. Brem is a world-renowned expert in breast cancer and the Director of the Breast Imaging and Interventional Center at the George Washington University.
  • Dr. Brem is the Chief Medical Officer of the Brem Foundation, a 501(c) 3 which began nearly 20 years ago, inspired by her mission and life story that is dedicated to the early detection of breast cancer.
  • "We are excited to have Dr. Brem's leadership at the Executive Director level to lead our Clinical and Regulatory strategy as our Chief Medical Officer."

LifeBridge Health selects NRC Health as its new patient experience partner

Retrieved on: 
Tuesday, August 29, 2023
CAHPS, Northwest Hospital, Partnership, LifeBridge Health, National Research Corporation, NRC, Health care, Overalls, Health, Consumer Assessment of Healthcare Providers and Systems, Grace Medical Center (Baltimore), Patient, Carroll Hospital, Sinai Hospital, Hospital, Pharmaceutical industry, Nursing

LINCOLN, Neb., Aug. 29, 2023 (GLOBE NEWSWIRE) -- LifeBridge Health has selected NRC Health to be its partner in providing Human Understanding® through personalized healthcare solutions and data-driven insights.

Key Points: 
  • LINCOLN, Neb., Aug. 29, 2023 (GLOBE NEWSWIRE) -- LifeBridge Health has selected NRC Health to be its partner in providing Human Understanding® through personalized healthcare solutions and data-driven insights.
  • LifeBridge Health is one of the largest, most comprehensive health systems in Maryland and includes Sinai Hospital, Northwest Hospital, Carroll Hospital, Levindale Hebrew Geriatric Center and Hospital, Grace Medical Center and related subsidiaries and affiliates.
  • “We’re excited to welcome LifeBridge Health to the NRC Health family and are looking forward to building a long-term relationship,” said Helen Hrdy, Chief Growth Officer at NRC Health.
  • These solutions help elevate humanized care, enhance the health care experience, and improve outcomes for patients and providers alike.

NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients

Retrieved on: 
Monday, March 20, 2023
Surgeon, Elective surgery, Spine, NUVA, NuVasive, Acquisition, Patient, Standard of care, SAN, LLD, Sinai Hospital, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, NSO, Food, Nursing, Medical device, S

The expanded clearance extends the clinical benefits of Precice to a wider range of patients.

Key Points: 
  • The expanded clearance extends the clinical benefits of Precice to a wider range of patients.
  • "Everyone faced with limb length discrepancy (LLD), especially pediatric patients, should have access to a non-invasive limb lengthening solution," said Pete Ligotti, leader of NuVasive Specialized Orthopedics (NSO).
  • As a division of NuVasive, NSO is focused on the design and innovation of disruptive orthopedic solutions for complex orthopedic reconstruction and limb lengthening.
  • "Precice has over a decade's worth of clinical data and has truly changed the standard of care for my patients," said Dr. John Herzenberg, director of pediatric orthopedics at Sinai Hospital.

John Marshall Bank Hires Melanie Williams as Senior Vice President, Director of Human Resources

Retrieved on: 
Thursday, February 23, 2023
Banking, Professional Services, Human Resources, Finance, Sinai Hospital, Senior, JMSB, Acquisition, Society, Society for Human Resource Management, Notre Dame, University of Maryland, College Park, Institute of Notre Dame, Human resources, Multimedia, Human, Management

John Marshall Bank (“JMB” or the “Bank”), subsidiary of John Marshall Bancorp, Inc. (the “Company”) (Nasdaq: JMSB), is proud to announce the hiring of Melanie Williams as Senior Vice President, Director of Human Resources.

Key Points: 
  • John Marshall Bank (“JMB” or the “Bank”), subsidiary of John Marshall Bancorp, Inc. (the “Company”) (Nasdaq: JMSB), is proud to announce the hiring of Melanie Williams as Senior Vice President, Director of Human Resources.
  • Ms. Williams will assume responsibility for leading human resources management, including overseeing the Bank’s compensation and benefits, diversity and inclusion, talent development, and talent acquisition efforts.
  • View the full release here: https://www.businesswire.com/news/home/20230223005242/en/
    Melanie Williams, Senior Vice President, Director of Human Resources (Photo: Business Wire)
    “Melanie is an accomplished human resources leader and we are excited to leverage her impressive experience to enhance our HR strategy,” stated Kent Carstater, Senior Executive Vice President, Chief Financial Officer.
  • In her over 14 years of experience, Ms. Williams most recently served as the Senior Vice President, Director of Human Resources, for the Harbor Bank of Maryland.

Maryland Businesses Reflect on Fruitful 2022 and Strong Start to 2023

Retrieved on: 
Tuesday, January 31, 2023
Linda, MII, SECU, Microsoft, SR, Education, Health, Workforce, Henry M. Jackson Foundation for the Advancement of Military Medicine, Peterson (company), Partnership, University System of Maryland, Daily Record, Maryland General Assembly, Community college, Longevity, Partner, Military medicine, IT service management, HJF, House, News, Potomac River, Memory, Acquisition, 2020 Maryland's 7th congressional district special election, Greater Baltimore Committee, University system, Morgan State University, Sinai Hospital, HBCU, AVD, Culture, Senate, USM, Growth, Organization, Woman, History, Maryland House of Delegates, Airline, Nursing, Management, Clutch

BALTIMORE, Jan. 31, 2023 /PRNewswire-PRWeb/ -- The Maryland Marketing Partnership, which helps drive Maryland's branding and marketing efforts to attract businesses, create jobs, and grow the state's economy, today shared a summary of the latest news from companies and organizations that are part of the partnership.

Key Points: 
  • "As we begin a new year, it fills me with great pride to watch our Maryland businesses cap 2022 off with success and start 2023 off with a bang," said Tom Riford, executive director of the Maryland Marketing Partnership.
  • Businesses here are always focused on long-term growth and longevity while continuing to strengthen their relationships with patrons and communities."
  • Through its funding and support, the Maryland Innovation Initiative (MII) continues to nurture tech-related businesses and retain a highly trained workforce.
  • The University System of Maryland (USM) , based in Baltimore and the state's public higher education system, was well-represented in both chambers of the 2023 Maryland General Assembly as they convened in early January.

ENT and Allergy Associates, LLP Board of Directors has selected Daniel Blum, MPA as its new Chief Executive Officer

Retrieved on: 
Tuesday, November 29, 2022
Human voice, Trustee, MPA, LLP, Phelps Memorial Hospital, Weill Cornell Medical Center, Hospital, Mount Sinai Hospital, Audiology, Asthma, ENT, White Plains Hospital, American Academy of Facial Plastic and Reconstructive Surgery, St. Vincent Hospital, Norwegian Asthma and Allergy Association, Partnership, Northwell Health, Physician, JAMA Facial Plastic Surgery, The Advisory Board Company, Patient, Montefiore Medical Center, Disorder, Sleep, Grace Medical Center (Baltimore), Gold, Sinai Hospital, American Cancer Society, Dizziness, Inner Ear, Health administration, Health, LifeBridge Health, EVP, Management, Medicine, New York University, Philosophy, MD

Tarrytown, New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA) the largest ENT, Allergy, and Audiology practice in the country is pleased to announce that Daniel Blum, MPA has been appointed as its new Chief Executive Officer, effective February 27, 2023.

Key Points: 
  • Tarrytown, New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA) the largest ENT, Allergy, and Audiology practice in the country is pleased to announce that Daniel Blum, MPA has been appointed as its new Chief Executive Officer, effective February 27, 2023.
  • Daniel Blum will succeed Robert Glazer who is stepping down from the CEO role after 25 years.
  • The Board is excited and looks forward to working with Dan and the senior management team to build on the companys momentum.
  • Dan is a thoughtful communicator and a resourceful and strategic-minded healthcare veteran with substantial experience working at the executive and board level.

WishBone Medical Appoints Dr. John E. Herzenberg to Board of Directors

Retrieved on: 
Wednesday, October 5, 2022
University of Maryland Rehabilitation & Orthopaedic Institute, Marketing, Orthopedic surgery, Hospital, Infection, Patient, U.S. News & World Report, University of Maryland Center for Environmental Science, Surgeon, Innovation, University, MD, CEO, International Center, Faculty, Sinai Hospital, Marketing communications, News, GLOBE, Boston University, Ponseti method, Elective surgery, Efficiency, FRCSC, Communication, CAT, Solution, History of the University of Maryland, College Park, Duke University, Medicine, Dentistry, USSR

WARSAW, Ind., Oct. 05, 2022 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of John Herzenberg, MD, FRCSC, FAAOS, to its board of directors.

Key Points: 
  • WARSAW, Ind., Oct. 05, 2022 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of John Herzenberg, MD, FRCSC, FAAOS, to its board of directors.
  • Dr. Herzenbergs clinical expertise coupled with his commitment to product innovation makes him a strong asset to our board, says Nick Deeter, Founder, Chairman, and CEO of WishBone Medical.
  • After medical school at Boston University, Herzenberg completed his residency in orthopedic surgery at Duke University and subspecialty training in pediatric orthopedics at the Hospital for Sick Children in Toronto.
  • Dr. Herzenberg co-founded the Maryland Center for Limb Lengthening & Reconstruction at Kernan Hospital.

New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions

Retrieved on: 
Tuesday, July 19, 2022
Health, Environment, Other Science, Green Technology, General Health, Research, Science, CDS, Diagnosis, American Academy, American College, Physician, American Academy of Allergy, Asthma, and Immunology, Hospital, Immunology, LH, NYSE, History, Allergy, Health, Risk, Medicine, Multimedia, Drug development, MedStar Franklin Square Medical Center, Anaphylaxis, Asthma, Patient, LinkedIn, VIT, American College of Allergy, Asthma and Immunology, Johns Hopkins University, Sinai Hospital, Pharmaceutical industry, LabCorp

To help facilitate more effective venom therapy, Labcorp (NYSE: LH), a leading global life sciences company, has launched its unique Labcorp Clinical Decision Support (CDS) interpretative test report for its Stinging Insect Component-Specific IgE Test that provides allergen test interpretation and treatment suggestions.

Key Points: 
  • To help facilitate more effective venom therapy, Labcorp (NYSE: LH), a leading global life sciences company, has launched its unique Labcorp Clinical Decision Support (CDS) interpretative test report for its Stinging Insect Component-Specific IgE Test that provides allergen test interpretation and treatment suggestions.
  • Over half of stinging insect patients test positive for allergic reactions to both honeybee and yellow jacket (wasp) venom.
  • Labcorps Stinging Insect Component-Specific IgE Testing helps identify the specific venom to which the patient is allergic and provides a more precise diagnosis to support venom immunotherapy.
  • The Labcorp CDS interpretive report follows the Practice Parameters and provides physicians comprehensive insight on diagnostic marker interpretation, treatment suggestions and guidance for managing venom and stinging insect therapy.